Elevated Src protein levels and activity are associated with the development and progression of a variety of cancers. The consequences of deregulated Src activity have been studied extensively in cell culture; however, the effects of this deregulation in vivo, as well as the mechanisms of Src-induced tumorigenesis, remain poorly understood. In this study, the effect of expressing wildtype and constitutively active Drosophila Src-family kinases (SFKs) in the developing eye was examined. Overexpression of either wild-type Drosophila SFK (Src64 and Src42) is sufficient to induce ectopic proliferation in G 1 /G 0 -arrested, uncommitted cells in eye imaginal discs. In addition, both kinases trigger apoptosis in vivo, in a dosage-dependent manner. Constitutively active mutants are hypermorphic as they trigger proliferation and death more potently than their wild-type counterparts. Moreover, SFK-induced proliferation and apoptosis are largely independent events, as blocking ectopic proliferation does not block cell death. Further, DCsk (the Drosophila homolog of the C-terminal Src kinase) phosphorylates and interacts genetically with the wild-type SFKs, but not with the constitutively active mutants in which a conserved C-terminal tyrosine was mutated to phenylalanine, providing the first in vivo evidence that Csk regulates SFKs during development through phosphorylation of their C-terminal tyrosine.
Introduction
The src gene was originally identified as an oncogene from the transforming gene of Rous-Sarcoma virus, v-src. Since then, nine other proteins with high amino-acid homology and structural similarities to Src have been identified in mammals. Src-family kinases (SFKs) are implicated in the regulation of varied cellular processes ranging from cell proliferation, survival and differentiation to cytoskeletal rearrangement. In addition, elevated Src expression and activity is associated with proliferative disorders, such as colon cancer, breast cancer, and a variety of other cancers (Frame, 2002) .
Mammalian SFK activity is negatively regulated by phosphorylation of a conserved tyrosine in the Cterminal tail of the protein (Tyr 527 in c-Src). The phosphorylated C-terminal tail interacts intramolecularly with the SH2 domain, giving rise to an inactive conformation. The highly transforming viral Src protein lacks this negative regulatory domain and, as a result, is kept constitutively active. In mammals, the protein tyrosine kinases Csk (C-terminal Src kinase) and Chk (Csk-homologous kinase), phosphorylate Src-family members in vitro at the conserved tyrosine, and this phosphorylation is largely implicated in the negative regulation of SFKs (Thomas and Brugge, 1997; Schwartzberg, 1998; Bjorge et al., 2000) . Overexpression of Csk in v-Crk/c-Src transformed cells results in the reversion to a normal phenotype and a reduced level of c-Src kinase activity (Sabe et al., 1992) . Moreover, homozygous csk mouse mutant embryos show an elevated level of Src, Fyn and Lyn kinase activity and decreased phosphorylation of the C-terminal tyrosine (Imamoto and Soriano, 1993; Nada et al., 1993) . However, it remains to be examined whether Csk regulates SFK activity during development through phosphorylation of SFKs' C-terminal kinase.
Despite extensive biochemical studies, there is a limited understanding of how elevated Src activity and/or protein levels may contribute to carcinogenesis. Cell culture studies have yielded variable results concerning the role(s) of v-src and c-src in proliferation. For example, expression of v-src or c-src can induce differentiation, proliferation or transformation depending on the cell type (Brown and Cooper, 1996; Biscardi et al., 1999; Bjorge et al., 2000; Frame, 2002) . Therefore, it is not clear whether SFK overexpression in different tissue culture systems accurately reflects the effect of elevated Src activity or expression in vivo. This underscores the need for in vivo model systems to study the role of SFKs in cell-cycle progression as well as to analyse the mechanisms of SFK regulation during development. Drosophila melanogaster has two c-src homologs (src64 and src42) and one csk homolog, with a high degree of homology to their mammalian counterparts (Simon et al., 1985; Takahashi et al., 1996; Stewart et al., 2003) . Studies in other laboratories have demonstrated that overexpression of src64 and src42 in the eye imaginal disc leads to defects in photoreceptor differentiation (Kussick et al., 1993; Takahashi et al., 1996) , but a direct role for src42 and src64 in undifferentiated cells has yet to be described.
In addition to promoting cell proliferation, overexpression of several oncogenes (e.g. myc and e2f) has also been shown to trigger cell death or to sensitize cells to apoptotic stimuli. It remains unclear whether apoptotic signals arise as a consequence of oncogeneinduced proliferation or, conversely, whether oncogenic signals independently activate both proliferative and cell death pathways (Evan, 1997; Evan and Littlewood, 1998; Guo and Hay, 1999; Green and Evan, 2002) . c-src and v-src exert opposing effects on programmed cell death in cell culture: while c-src overexpression sensitizes cells to apoptotic stimuli (Aouacheria et al., 2002; Boudny and Nakano, 2002) , v-src overexpression in both QNC and immortalized fibroblasts appears to protect cells from apoptosis upon serum withdrawal (Johnson et al., 2000) . However, recent findings point to a dual role of v-src in activating both pro-and antiapoptotic pathways (Webb et al., 2000) .
Here, we report that overexpression of Src64 or Src42 in the developing Drosophila eye disrupts normal eye development and induces uncommitted, G 1 /G 0 -arrested cells, to re-enter the cell cycle. We also show that SFKs are strong inducers of apoptosis in developing tissues. In addition, we find that apoptosis does not occur as a consequence of deregulated proliferation; rather, proliferative and death pathways are triggered independently, since blocking proliferation by human p21 overexpression fails to supress SFK-induced cell death. Finally, we provide evidence that Csk is necessary and sufficient for the regulation of SFK activity in vivo through phosphorylation of the conserved C-terminal tyrosine.
Our findings show for the first time that overexpression of wild-type or constitutively active SFKs alone is sufficient to induce proliferation in vivo. However, this deregulated proliferation does not lead to tumorigenesis because, unlike activated Src in mammalian tissue culture systems, increased SFK protein levels and increased activity also induce cell death.
Results

Overexpression of Src64 and Src42 disrupts normal eye development
The adult Drosophila compound eye develops from larval monolayer epithelial structures called eye imaginal discs. Differentiation begins during the third larval instar and progresses from the posterior to the anterior end of the eye disc in a wave marked by a dorsal-ventral indentation in the disc's apical surface, the morphogenetic furrow (MF). Cells ahead of the MF proliferate asynchronously and arrest at G 1 just anterior to the MF. These G 1 -arrested cells either differentiate into ommatidial preclusters or divide synchronously in a second mitotic wave posterior to the furrow to give rise to the remaining cells needed to complete an ommatidium. No Src64 and Src42 induce cell proliferation and death
LG Pedraza et al cell divisions are observed posterior to the second mitotic wave (Wolff and Ready, 1991) . Multiple, independent transgenic Drosophila lines carrying either the wild-type or the constitutively active forms of the two Drosophila Src homologs, Src64 and Src42 (UAS-Src64, UAS-Src42, UAS-Src64YF and UAS-Src42YF, respectively), were generated to examine the effects of overexpression of these proteins in the developing eye. The GMR-Gal4 driver was used to direct the ectopic overexpression of these proteins to cells posterior to the MF. The resultant phenotypes were classified into three different phenotypic groups at 251C: strong (str.) moderate (mod.) and weak (wk.) (Table 1) . Since Gal4 activity in Drosophila is temperaturesensitive -with higher activity at higher temperatures -different expression levels of any UAS-transgene can be achieved by altering the temperature (Duffy, 2002) . We find that the effects of both constitutively active and wild-type SFKs overexpression are dosage-sensitive as transgenic lines raised at 181C, rather than 251C, show less severe defects in eye development. For example, GMR-Gal4/UAS-Src64 and GMRGal4/UAS-Src42 moderate transgenic lines raised at 181C have slightly protruding rough eyes with multiple ectopic bristles ( Figure 1a ,b and Table 1 ); raising the temperature to 251C gives rise to a rougher eye with some lens blisters and missing bristles ( Figure 1c and Table 1 ). Two copies of these transgenes at 251C result in eyes devoid of photoreceptor and accessory cells ( Figure 1d and data not shown). GMR-Gal4/UAS-Src42 and GMR-Gal4/ UAS-Src64 strong transgenic lines raised at 181C give rise to a small, rough-eye phenotype with some missing bristles and lens blisters ( Figure 1e and Table 1) , while incubation at 251C results in the complete ablation of photoreceptor and accessory cells ( Figure 1f and Table 1 ). Constitutively active forms of either Src64 or Src42 show consistently stronger phenotypes than their wild-type counterparts, as strong constitutively active lines of both Src64 and Src42 are lethal at 251C and display the no-photoreceptor and accessory cells phenotype at 181C (Figure 1g ,h and Table 1 ), suggesting that activating mutations in Src42 and Src64 are hypermorphic rather than neomorphic.
Overexpression of Src64 and Src42 leads to ectopic proliferation in uncommitted cells posterior to the MF
Since the presence of ectopic bristles can be indicative of extra cell proliferation, we investigated whether SFKs induce ectopic cell proliferation during eye development. To determine the effects of overexpressing wild-type and constitutively active Src64 and Src42 on cell proliferation, third-instar eye-imaginal discs were labeled with BrdU and stained with anti-BrdU or with antiphosphohistone H3 antibodies to visualize cells undergoing either DNA synthesis or mitosis, respectively. In the wild-type eye disc, few cell divisions were observed posterior to the second mitotic wave (Figure 2a ,e). In contrast, an increase in both BrdU and histone H3 labeling was observed in cells posterior to the second 
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LG Pedraza et al mitotic wave in GMR-Gal4/UAS-Src64, UAS-Src64YF (Fig 2b,d ,e), UAS-Src42 and UAS-Src42YF (Figure 2e and data not shown) eye imaginal discs when compared to wild-type discs, indicating that SFKs induce cells to go through a full round of cell division. There was a statistically significant difference (Po0.01) between the number of histone H3-positive cells posterior to the second mitotic wave in wild-type and GMR-Gal4/UASSrc64, UAS-Src42, UAS-Src64YF and UAS-Src42YF (Figure 2e ). In order to determine which cells undergo extra rounds of cell division, eye discs were labeled with BrdU and co-stained with anti-BrdU and anti-Elav antibodies. In wild-type discs, Elav-positive cells have exited the cell cycle and are committed to a neuronal fate; while Elavnegative cells remain uncommitted and arrested at G 1 / G 0 . Double labeling experiments of flies expressing either activated or wild-type SFKs show that Elav and BrdU-positive cells do not co-localize (Figure 2b,d and data not shown) and that it is uncommitted cells, normally arrested at G 1 /G 0 , that are being recruited to enter the cell cycle. In addition, expression of both wildtype and constitutively active SFKs in differentiating cells (using an Elav-Gal4 driver) does not give rise to ectopic cell proliferation (data not shown), further confirming that SFKs cannot drive differentiating photoreceptor cells to proliferate. Together, these results suggest that SFK expression induces uncommitted cells, normally arrested at G 1 /G 0 , to re-enter the cell cycle.
Overexpression of Src64 and Src42 leads to increased cell death
The adult eye phenotype resulting from strong SFK overexpression, suggests that SFKs may also trigger apoptosis. In order to test whether SFKs induce apoptosis, third instar eye-imaginal discs were stained with acridine orange. Eye discs from flies expressing GMR-driven UAS-Src64 or UAS-Src42 show increased acridine orange staining when compared to wild-type discs (Figure 3b ,c,e). Moreover, eye discs from flies overexpressing the constitutively active forms of these proteins show a higher amount of staining than their wild-type counterparts (Figure 3d ,f), indicating that SFK-induced cell death is dosage-dependent, and that the constitutively active proteins are more potent inducers of apoptosis in vivo.
Src64 and Src42 induce proliferation and apoptosis through independent pathways
In order to test whether SFK-induced cell death is a consequence of deregulated proliferation or is triggered by independent mechanisms, we asked whether blocking ectopic proliferation induced by SFKs could inhibit cell death. The human cyclin-dependent kinase inhibitor p21 is a potent inhibitor of cell proliferation in humans and Drosophila (de Nooij and Hariharan, 1995) . Co-expression of p21 with Drosophila SFKs using the GMR-Gal4 driver resulted in a significant enhancement of the SFKinduced phenotype in strong, moderate and weak SFK transgenic lines (Figure 4a ,b,e,f and data not shown). BrdU labeling of eye imaginal discs indicated that p21 was able to block SFK-induced ectopic cell proliferation, as well as most of the second mitotic wave ( Figure  4c,d and data not shown). However, acridine orange staining reveals that there was no significant change in the cell death levels between flies overexpressing SFKs Ectopically proliferating cells can be seen posterior to the second mitotic wave. The number of histone-H3 positive cells posterior to the second mitotic wave was counted and the student's t-test was used to perform pairwise comparisons between wild-type histone-H3 counts and those of each transgenic line. There is a statistically significant difference (Po0.01) between wild-type controls and Src64 (P ¼ 9.6 Â 10
). Differentiating and proliferating cells do not colocalize, indicating that it is cells uncommitted to a neuronal fate that undergo extra rounds of cell division Src64 and Src42 induce cell proliferation and death LG Pedraza et al that carry a copy of p21 and SFK controls (Figure 4g ,h and data not shown). In addition, overexpression of p21 alone did not induce ectopic cell death (data not shown). This suggests that SFKs induce cell proliferation and death via parallel pathways, since blocking proliferation does not block cell death. The resultant phenotype is most likely the consequence of the balance between these two pathways.
DCsk phosphorylates Src42 and Src64 in vitro
In Drosophila, csk mutant larvae display an overproliferation phenotype similar to that of SFK overexpression (Stewart et al., 2003) , which raises the possibility that the cskÀ/À overproliferation phenotype is caused, at least in part, by excess SFK activity. In order to investigate how SFK-mediated cell proliferation and cell death are regulated, the effect of the Drosophila homolog of Csk on SFK activity was tested. In vitro phosphorylation experiments carried out using GST-fusion proteins showed that both SFKs have robust autophosphorylation activities ( Figure 5b , Lane 1). Mutation of a key lysine (K276 and K312 in Src42 and Src64, respectively) to arginine in the activating loop of the protein eliminates autophosphorylation (Figure 5b , Lane 2). In order to visualize Csk phosphorylation activity, we incubated Src64KR or Src42KR with GST-conjugated Csk. GST-Csk was able to phosphorylate both Drosophila SFKs (Figure 5b , Lane 4). This phosphorylation occurs at evolutionarily conserved C-terminal tyrosines (Figure 5a ), as mutation of these tyrosines to phenylalanine completely abrogates the ability of Csk to phosphorylate SFKs (Figure 5b , Lane 5).
DCsk interacts with Src64 and Src42 in vivo
We sought to further test whether the in vitro interaction between Csk and Src64 or Src42 had significance in vivo. Expression of Csk under the control of GMRGal4 did not affect eye development (data not shown); however, expression of Csk suppresses the Src64 or Src42-induced rough-eye phenotype (Figure 6a-d) , as well as the extra cell proliferation and cell death phenotype caused by overexpression of wild-type Src64 (Figure 2c ) or Src42 (data not shown). In contrast, Csk overexpression cannot suppress the adult eye or the larval cellproliferation and cell death phenotype caused by constitutively active versions of either SFKs when either strong or weak Src64YF and Src42YF transgenic lines are used (Figure 6i-p and data not shown) . Further, deletion of one copy of endogenous csk in GMRGal4/ UAS-Src64 and GMRGal4/UAS-Src42 animals enhances SFK-induced defects (Figure 6e-h ). Taken together, these results indicate that Csk plays a conserved in vivo role in the negative regulation of SFKs and that the C-terminal tyrosine is crucial for this regulation. Furthermore, it is likely that the overproliferation defects caused by loss of csk are in part due to loss of SFK inhibition. 
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Discussion
The src oncogene is associated with the development of a variety of cancers, in particular colon and breast cancer; however, we still have a limited understanding of its specific contributions to the development of malignancies and the effects of its overexpression in vivo. To assess the role of SFKs in vivo in cellular proliferation and tumorigenesis in the context of both proliferating and differentiating cells, both wild-type and constitutively active forms of SFKs were expressed in cells posterior to the MF in the developing eye. Ectopic expression of either wild-type or constitutively active forms of SFKs has profound effects on eye development. The phenotype observed is dosage-sensitive and ranges from rough, protruding eyes with multiple ectopic bristles when the proteins are expressed at low levels, to eyes completely devoid of photoreceptors at higher expression levels. The difference between the constitutively active and wild-type versions of these proteins seems to be one of expression levels, with strong wild-type lines having similar effects to weaker constitutively active ones. Unlike mammalian fibroblasts that are able to grow and develop normally when c-Src is overexpressed, in Drosophila eye discs, overexpression of the wild-type proteins has severe phenotypic effects. These findings are consistent with previous reports that show that overexpressed wild-type Src64 in Schneider cells behaves like an activated kinase (Kussick and Cooper, 1992) . The bipartite Gal4/UAS expression system can be used to analyse the consequences of SFK overexpression on cell cycle progression in vivo in three different subsets of cells: proliferating cells of the second mitotic wave, uncommitted cells arrested in G 1 /G 0 and in postmitotic, differentiating cells. SFK overexpression leads to ectopic proliferation in normally postmitotic cells. Double labeling with BrdU and Elav shows that SFK overexpression does not induce differentiating cells to re-enter the cell cycle, but rather, drives cells arrested at G 1 /G 0 , posterior to the second mitotic wave, to proliferate. This was further confirmed by the inability of SFKs to induce cell proliferation when overexpressed only in differentiating cells (using the ElavGal4 driver). Further, we show that overexpression of either constitutively active or wild-type SFKs also induces apoptosis, leading to the complete ablation of adult eye structures when SFKs are expressed at high levels. 
It has been proposed that proliferative and apoptotic pathways are inextricably linked, possibly as an evolutionary defense against tumor progression. Unregulated oncogenic signals will thus trigger both proliferation and death unless a separate signal that suppresses apoptosis is simultaneously present. In this context, cancer arises as a consequence of deregulated cell proliferation with simultaneous suppression of apoptosis, these two events providing a platform for ineluctable cell expansion (Evan, 1997; Evan and Littlewood, 1998) . However, in the case of Src, this has not yet been proven in mammalian systems, as the effects of Src activation on proliferation and death in cell culture depend greatly on the particular cell line used. Further, SFK-induced breast and astrocytoma transgenic cancer models show a long latency-period before the appearance of tumors with high proliferative activity, indicating that neither vsrc nor activated c-src alone are sufficient to drive tumor formation (Webster et al., 1995; Weissenberger et al., 1997) . It remains unclear whether the increased proliferative activity of the tumor is due to elevated Src activity alone or to acquired secondary mutations. We provide in vivo evidence that either overexpression or constitutive activation of SFKs alone is sufficient to drive proliferation.
In addition, high levels of wild-type or constitutively active SFK expression also trigger cell death. These observations support a model in which a single oncogene does not suffice to drive tumorigenesis in vivo and highlights the fact that secondary mutations are needed for tumor formation. Our work also supports the notion that these two effects of SFK activation in vivoproliferation and death -are triggered through independent pathways, since blocking proliferation with human p21 did not affect SFK-induced cell death, and underscores the fact that oncogene-activation of proapoptotic pathways involves discrete mechanisms that likely represent an evolutionary defense against cancer progression. It is possible that SFK-induced apoptosis may trigger proliferation as a means to compensate cell number and maintain tissue size. However, we do not favor this model since apoptotic genetic alterations have not been reported to induce cell proliferation in the eye disc (Igaki et al., 2000 (Igaki et al., , 2002 Ollmann et al., 2000) . Interestingly, overexpression of neither baculovirus p35 nor IAPs (inhibitor of apoptosis proteins) was able to suppress SFK-induced cell death (LP and TX, unpublished observations), raising the possibility that SFKs trigger cell death through a caspase-independent pathway. Elucidation of the mechanisms of SFK-induced cell death will likely reveal additional contributions of SFKs to cancer progression when cell death signals are suppressed and provide valuable targets for cancer therapy.
Hypomorphic Src64 alleles were not found to have an effect on Drosophila eye imaginal disc development (Dodson et al., 1998) ; however, these Src64 alleles still show significant Src64 expression in eye imaginal discs (LP and TX, unpublished observations) and only delete one of the two predicted Src64 transcripts. Generation of null alleles of Src64 may uncover an endogenous role for Src64 in cell proliferation and death. Studies with loss-offunction Src42 have uncovered a role for Src42 in dorsal closure during development (Tateno et al., 2000) ; it remains to be determined whether Src42 normally regulates cell proliferation and death during development.
Csk was originally identified as a potential regulator of SFK activity by virtue of its ability to phosphorylate SFKs and negatively regulate their kinase activity in vitro. Csk knockout mice were found to display elevated levels of SFK kinase activity, suggesting that Csk plays an in vivo role in the regulation of SFK activity; however, these findings do not rule out the possibility that Csk may regulate SFKs by other means, such as through other SFK-interacting proteins. We provide direct genetic evidence that Csk regulates SFK activity in vivo through phosphorylation of the conserved C-terminal tyrosine. Several lines of evidence indicate that SFK activity is regulated by Csk in Drosophila. First, studies carried out in our laboratory have shown that mutations in the Drosophila homolog of Csk (dcsk) result in overproliferation of eye imaginal discs and that Dcsk can phosphorylate one of the Drosophila SFKs (Src42) (Stewart et al., 2003) . Second, in vitro phosphorylation assays shown here indicate that Csk is able to phosphorylate both Src64 and Src42, and that mutation of the conserved Cterminal tyrosines (T547 and T511, respectively) to phenylalanine abrogates the ability of Csk to phosphorylate SFKs. Third, overexpression of Csk can supress the wild-type SFK overexpression phenotype but not that of constitutively active SFKs, in which the C-terminal tyrosines have been mutated to phenylalanine. Fourth, deletion of one copy of endogenous csk enhances the SFK-overexpression phenotype. These results provide the first genetic evidence that Drosophila Csk negatively regulates both Src42 and Src64 in vivo by phosphorylation of a conserved C-terminal kinase. Studies in our laboratory have shown that csk also interacts with lats to regulate cell proliferation and tissue size (Stewart et al., 2003) . In this manuscript, we have shown that Csk directly phosphorylates Src64 and Src42 proteins and that Csk is no longer able to block Srcinduced phenotypes when the C-terminal Csk phosphorylation sites in Src proteins are mutated. Thus, the suppression of Src-caused phenotypes by Csk is likely directly mediated through the phosphorylation of Src by Csk, and is not the consequence of Csk's effect on Lats. Together, these data support the notion that both Lats and Src molecules are Csk substrates.
Since the proto-oncogene function of SFKs is conserved from flies to humans, further studies on the mechanisms of SFK-induced proliferation and death in Drosophila will greatly enhance our understanding of the mechanisms of Src-induced tumorigenesis and may help to define possible clinical targets for SFK-mediated tumor progression. Furthermore, it would be of interest to use Drosophila as a model organism to identify other mutations that, in combination with SFK-overexpression, would lead to carcinogenesis and to investigate the mechanism of such cooperation.
Materials and methods
Fly genetics
Wild-type src64, src42 and csk cDNA were cloned into the pUAST vector for P-element transformation (Brand and Perrimon, 1993) . The Src64YF and Src42YF constitutively active mutants were generated by PCR, confirmed by sequencing and cloned into the pUAST vector. UAS-p21 and GMRGal4 were generous gifts from I Hariharan and M Freeman respectively.
Histology
Eye discs from wandering third-instar larvae were incubated in 1 : 100 cell proliferation labeling reagent in PBS (Amersham Pharmacia RPN201) for 45 min at room temperature. Tissues were then fixed in 4% paraformaldehyde and stained with mouse monoclonal anti-BrdU antibody (Sigma 34750) at 1 : 200 dilution. The rat monoclonal anti-Elav antibody, developed by Gerald Rubin, was obtained from the Developmental Studies Hybridoma Bank (7E8A10) and used at 1 : 20 dilution. Acridine orange staining of third-instar larvae was carried out as described (Du et al., 1996) . Samples for s.e.m. were prepared as described (Kimmel et al., 1990) .
Biochemistry
GST-fusion proteins were produced in BL21 bacteria and purified according to the manufacturer's protocol. The kinase assays were performed as described (Bougeret et al., 1993) . Equal amounts of GST-fusion proteins were loaded in each lane (200 ng) and checked by Coomasie Blue staining.
